Jack McGovern

Comprehensive Clinical Development is clinical research company focusing on clinical pharmacology, central nervous system (CNS) trials. Comprehensive continues to dominate the therapeutic development process by standing as a strategic partner poised with deep expertise in central nervous system disorders and multiple therapeutic areas, research methodologies, regulatory requisites and evolving patient needs. For over 17 years, Comprehensive Clinical Development’s team has built and maintained an outstanding record for consistently delivering quality results on time and within budget, helping pharmaceutical and biotech companies worldwide deliver new treatments and therapies. Visit our website www.ComprehensiveCD.com for additional information.